User menu

Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome

Bibliographic reference Mutemberezi, Valentin ; Masquelier, Julien ; Guillemot-Legris, Owein ; Muccioli, Giulio. Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome. In: Analytical and Bioanalytical Chemistry, Vol. 408, no. 3, p. 733-745 (2016)
Permanent URL http://hdl.handle.net/2078.1/173256
  1. Nagao Koji, Yanagita Teruyoshi, Bioactive lipids in metabolic syndrome, 10.1016/j.plipres.2007.12.002
  2. Muccioli Giulio G, Naslain Damien, Bäckhed Fredrik, Reigstad Christopher S, Lambert Didier M, Delzenne Nathalie M, Cani Patrice D, The endocannabinoid system links gut microbiota to adipogenesis, 10.1038/msb.2010.46
  3. Perry Rachel J., Samuel Varman T., Petersen Kitt F., Shulman Gerald I., The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes, 10.1038/nature13478
  4. Asrih M, Jornayvaz FR (2015) Mol Cell Endocrinol
  5. Gouveia-Figueira Sandra, Nording Malin L., Development and Validation of a Sensitive UPLC-ESI-MS/MS Method for the Simultaneous Quantification of 15 Endocannabinoids and Related Compounds in Milk and Other Biofluids, 10.1021/ac403352e
  6. Basit A, Piomelli D, Armirotti A (2015) Anal Bioanal Chem
  7. Griffiths William J., Crick Peter J., Wang Yuqin, Methods for oxysterol analysis: Past, present and future, 10.1016/j.bcp.2013.01.027
  8. Griffiths William J., Crick Peter J., Wang Yuchen, Ogundare Michael, Tuschl Karin, Morris Andrew A., Bigger Brian W., Clayton Peter T., Wang Yuqin, Analytical strategies for characterization of oxysterol lipidomes: Liver X receptor ligands in plasma, 10.1016/j.freeradbiomed.2012.07.027
  9. Poli Giuseppe, Biasi Fiorella, Leonarduzzi Gabriella, Oxysterols in the pathogenesis of major chronic diseases, 10.1016/j.redox.2012.12.001
  10. Murdolo Giuseppe, Bartolini Desirée, Tortoioli Cristina, Piroddi Marta, Iuliano Luigi, Galli Francesco, Lipokines and oxysterols: Novel adipose-derived lipid hormones linking adipose dysfunction and insulin resistance, 10.1016/j.freeradbiomed.2013.08.007
  11. Larsen Philip J., Tennagels Norbert, On ceramides, other sphingolipids and impaired glucose homeostasis, 10.1016/j.molmet.2014.01.011
  12. Bjorkhem I., Oxysterols: Friends, Foes, or Just Fellow Passengers?, 10.1161/01.atv.0000013312.32196.49
  13. Iuliano Luigi, Pathways of cholesterol oxidation via non-enzymatic mechanisms, 10.1016/j.chemphyslip.2011.06.006
  14. Bodin Karl, Andersson Ulla, Rystedt Eva, Ellis Ewa, Norlin Maria, Pikuleva Irina, Eggertsen Gösta, Björkhem Ingemar, Diczfalusy Ulf, Metabolism of 4β-Hydroxycholesterol in Humans, 10.1074/jbc.m201712200
  15. Olsen Brett N., Schlesinger Paul H., Ory Daniel S., Baker Nathan A., Side-chain oxysterols: From cells to membranes to molecules, 10.1016/j.bbamem.2011.06.014
  16. Olkkonen Vesa M., Béaslas Olivier, Nissilä Eija, Oxysterols and Their Cellular Effectors, 10.3390/biom2010076
  17. Olkkonen Vesa M., Li Shiqian, Oxysterol-binding proteins: Sterol and phosphoinositide sensors coordinating transport, signaling and metabolism, 10.1016/j.plipres.2013.06.004
  18. Tremblay-Franco M, Zerbinati C, Pacelli A, Palmaccio G, Lubrano C, Ducheix S, Guillou H, and Iuliano L (2015) Steroids
  19. Wooten Joshua S., Wu Huaizhu, Raya Joe, Perrard Xiaoyuan Dai, Gaubatz John, Hoogeveen Ron C., The Influence of an Obesogenic Diet on Oxysterol Metabolism in C57BL/6J Mice, 10.1155/2014/843468
  20. Castro Bruno M., Prieto Manuel, Silva Liana C., Ceramide: A simple sphingolipid with unique biophysical properties, 10.1016/j.plipres.2014.01.004
  21. Maceyka Michael, Spiegel Sarah, Sphingolipid metabolites in inflammatory disease, 10.1038/nature13475
  22. Cinar Resat, Godlewski Grzegorz, Liu Jie, Tam Joseph, Jourdan Tony, Mukhopadhyay Bani, Harvey-White Judith, Kunos George, Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides : Hepatology, Vol. 00, No. X, 2013 Cinar et al., 10.1002/hep.26606
  23. Hanamatsu H, Ohnishi S, Sakai S, Yuyama K, Mitsutake S, Takeda H, Hashino S, Igarashi Y, Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults, 10.1038/nutd.2014.38
  24. Turpin Sarah M., Nicholls Hayley T., Willmes Diana M., Mourier Arnaud, Brodesser Susanne, Wunderlich Claudia M., Mauer Jan, Xu Elaine, Hammerschmidt Philipp, Brönneke Hella S., Trifunovic Aleksandra, LoSasso Giuseppe, Wunderlich F. Thomas, Kornfeld Jan-Wilhelm, Blüher Matthias, Krönke Martin, Brüning Jens C., Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance, 10.1016/j.cmet.2014.08.002
  25. Raichur Suryaprakash, Wang Siew Tein, Chan Puck Wee, Li Ying, Ching Jianhong, Chaurasia Bhagirath, Dogra Shaillay, Öhman Miina K., Takeda Kosuke, Sugii Shigeki, Pewzner-Jung Yael, Futerman Anthony H., Summers Scott A., CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance, 10.1016/j.cmet.2014.09.015
  26. Alhouayek Mireille, Muccioli Giulio G., Harnessing the anti-inflammatory potential of palmitoylethanolamide, 10.1016/j.drudis.2014.06.007
  27. Silvestri Cristoforo, Di Marzo Vincenzo, The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders, 10.1016/j.cmet.2013.03.001
  28. Osei-Hyiaman Douglas, DePetrillo Michael, Pacher Pál, Liu Jie, Radaeva Svetlana, Bátkai Sándor, Harvey-White Judith, Mackie Ken, Offertáler László, Wang Lei, Kunos George, Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity, 10.1172/jci200523057
  29. Matias Isabel, Gonthier Marie-Paule, Orlando Pierangelo, Martiadis Vassilis, De Petrocellis Luciano, Cervino Cristina, Petrosino Stefania, Hoareau Laurence, Festy Franck, Pasquali Renato, Roche Regis, Maj Mario, Pagotto Uberto, Monteleone Palmiero, Di Marzo Vincenzo, Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia, 10.1210/jc.2005-2679
  30. Cristino Luigia, Becker Thorsten, Di Marzo Vincenzo, Endocannabinoids and energy homeostasis: An update : Regolatory Role of Endocannabinoids in Obesity, 10.1002/biof.1168
  31. Kajiwara K., Ikeda A., Aguilera-Romero A., Castillon G. A., Kagiwada S., Hanada K., Riezman H., Muniz M., Funato K., Osh proteins regulate COPII-mediated vesicular transport of ceramide from the endoplasmic reticulum in budding yeast, 10.1242/jcs.132001
  32. Schiffmann Susanne, Birod Kerstin, Männich Julia, Eberle Max, Wegner Marthe-Susanna, Wanger Ruth, Hartmann Daniela, Ferreiros Nerea, Geisslinger Gerd, Grösch Sabine, Ceramide metabolism in mouse tissue, 10.1016/j.biocel.2013.06.004
  33. Meljon Anna, Theofilopoulos Spyridon, Shackleton Cedric H. L., Watson Gordon L., Javitt Norman B., Knölker Hans-Joachim, Saini Ratni, Arenas Ernest, Wang Yuqin, Griffiths William J., Analysis of bioactive oxysterols in newborn mouse brain by LC/MS, 10.1194/jlr.d028233
  34. Meljon Anna, Wang Yuqin, Griffiths William J., Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse, 10.1016/j.bbrc.2014.01.153
  35. Maroof N, Ravipati S, Pardon MC, Barrett DA, Kendall DA (2014) J Alzheimers Dis 42:227–245
  36. Muccioli Giulio G., Stella Nephi, An optimized GC–MS method detects nanomolar amounts of anandamide in mouse brain, 10.1016/j.ab.2007.09.030
  37. AOAC OFFICIAL METHODS OF ANALYSIS. Guidelines for standard method performance requirements, appendix F. 1–17. 2012. AOAC INTERNATIONAL. Ref Type: Online Source
  38. V Sonawane Lalit, Bioanalytical Method Validation and Its Pharmaceutical Application- A Review, 10.4172/2153-2435.1000288
  39. Cummings J, Raynaud F, Jones L, Sugar R, Dive C, Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs, 10.1038/sj.bjc.6605910
  40. Lee Jean W., Devanarayan Viswanath, Barrett Yu Chen, Weiner Russell, Allinson John, Fountain Scott, Keller Stephen, Weinryb Ira, Green Marie, Duan Larry, Rogers James A., Millham Robert, O'Brien Peter J., Sailstad Jeff, Khan Masood, Ray Chad, Wagner John A., Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement, 10.1007/s11095-005-9045-3
  41. Hoffman David, Kringle Robert, A Total Error Approach for the Validation of Quantitative Analytical Methods, 10.1007/s11095-007-9242-3
  42. Shabir Ghulam A., Validation of high-performance liquid chromatography methods for pharmaceutical analysis, 10.1016/s0021-9673(02)01536-4
  43. Triba Mohamed N., Le Moyec Laurence, Amathieu Roland, Goossens Corentine, Bouchemal Nadia, Nahon Pierre, Rutledge Douglas N., Savarin Philippe, PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters, 10.1039/c4mb00414k
  44. Karuna Ratna, Christen Isabelle, Sailer Andreas W., Bitsch Francis, Zhang Juan, Detection of dihydroxycholesterols in human plasma using HPLC–ESI-MS/MS, 10.1016/j.steroids.2015.02.002
  45. Narayanaswamy Rohini, Iyer Vignesh, Khare Prachi, Bodziak Mary Lou, Badgett Darlene, Zivadinov Robert, Weinstock-Guttman Bianca, Rideout Todd C., Ramanathan Murali, Browne Richard W., Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS, 10.1371/journal.pone.0123771
  46. Razzazi-Fazeli E, Kleineisen S, Luf W, Determination of cholesterol oxides in processed food using high-performance liquid chromatography–mass spectrometry with atmospheric pressure chemical ionisation, 10.1016/s0021-9673(00)00719-6
  47. Georgiou Christiana A., Constantinou Michalis S., Kapnissi-Christodoulou Constantina P., Sample preparation: A critical step in the analysis of cholesterol oxidation products, 10.1016/j.foodchem.2013.08.123
  48. Helmschrodt C., Becker S., Thiery J., Ceglarek U., Preanalytical standardization for reactive oxygen species derived oxysterol analysis in human plasma by liquid chromatography–tandem mass spectrometry, 10.1016/j.bbrc.2013.12.087
  49. Miyoshi Noriyuki, Iuliano Luigi, Tomono Susumu, Ohshima Hiroshi, Implications of cholesterol autoxidation products in the pathogenesis of inflammatory diseases, 10.1016/j.bbrc.2013.12.107
  50. Cyster Jason G., Dang Eric V., Reboldi Andrea, Yi Tangsheng, 25-Hydroxycholesterols in innate and adaptive immunity, 10.1038/nri3755
  51. Balvers Michiel G.J., Wortelboer Heleen M., Witkamp Renger F., Verhoeckx Kitty C.M., Liquid chromatography–tandem mass spectrometry analysis of free and esterified fatty acid N-acyl ethanolamines in plasma and blood cells, 10.1016/j.ab.2012.11.008
  52. Amano Shinya U., Cohen Jessica L., Vangala Pranitha, Tencerova Michaela, Nicoloro Sarah M., Yawe Joseph C., Shen Yuefei, Czech Michael P., Aouadi Myriam, Local Proliferation of Macrophages Contributes to Obesity-Associated Adipose Tissue Inflammation, 10.1016/j.cmet.2013.11.017
  53. Teodoro João S., Varela Ana T., Rolo Anabela P., Palmeira Carlos M., High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes, 10.1007/s12263-014-0406-6
  54. de Aguiar Vallim Thomas Q., Tarling Elizabeth J., Edwards Peter A., Pleiotropic Roles of Bile Acids in Metabolism, 10.1016/j.cmet.2013.03.013
  55. Engeli Stefan, Lehmann Anne-Christin, Kaminski Jana, Haas Verena, Janke Jürgen, Zoerner Alexander A., Luft Friedrich C., Tsikas Dimitrios, Jordan Jens, Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects : Endocannabinoids and High-Fat Diet, 10.1002/oby.20728